135 results on '"Cabergoline -- Research"'
Search Results
52. New Dopaminergic Antiparkinsonism Agents Study Findings Have Been Reported from Department of Obstetrics and Gynecology (A Modified Gnrh Antagonist Method In Combination With Letrozole, Cabergoline, and Gnrh Antagonist for Pcos: Safe and ...)
53. New Pituitary Adenoma Study Findings Have Been Reported by Investigators at IRCCS Ospedale Policlinico San Martino (Clinical and Radiological Presentation of Parasellar Ectopic Pituitary Adenomas: Case Series and Systematic Review of the ...)
54. Reports Summarize Prolactinoma Findings from University of Liege [The Clinical and Therapeutic Profiles of Prolactinomas Associated With Germline Pathogenic Variants In the Aryl Hydrocarbon Receptor Interacting Protein (Aip) Gene]
55. Research Results from Duke University Update Knowledge of Cushing's Syndrome (Successful Management of Cushing Syndrome From Ectopic ACTH Secretion in an Adolescent With Osilodrostat)
56. Studies from Cairo University in the Area of Dopaminergic Antiparkinsonism Agents Published (Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats)
57. Study Results from University of Arizona Update Understanding of Gene Editing (A Prolactin-dependent Sexually Dimorphic Mechanism of Migraine Chronification)
58. Researchers at Bangabandhu Sheikh Mujib Medical University Target Endometriosis (The Effects of Cabergoline Compared to Dienogest in Women with Symptomatic Endometrioma)
59. Study Results from Hedi Chaker Hospital Broaden Understanding of Hypertension (Diagnosis and management of pituitary apoplexy: a Tunisian data)
60. Research on Dopaminergic Antiparkinsonism Agents Reported by a Researcher at Medical University of Silesia (Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study)
61. Studies from INCLIVA Yield New Data on Endometriosis [A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment]
62. Studies from Bam University of Medical Sciences in the Area of Nanocomposites Reported (A Sensitive Sio2@fe3o4/go Nanocomposite Modified Ionic Liquid Carbon Paste Electrode for the Determination of Cabergoline)
63. Studies from Hospital Especialidades Yield New Data on Acromegaly (Surgical and Pharmacological Outcomes In Acromegaly: Real-life Data From the Mexican Acromegaly Registry)
64. Study Results from Department of Cardiology Update Understanding of Prolactinoma (Incidence of cabergoline associated valvulopathy in primary care patients with prolactinoma using hard cardiac endpoints)
65. Study Findings from Kerman University of Medical Sciences Broaden Understanding of Nanocomposites (Iron Molybdenum Oxide-modified Screen-printed Electrode: Application for Electrocatalytic Oxidation of Cabergoline)
66. Research Results from Seth GS Medical College and KEM Hospital Update Understanding of Dopaminergic Antiparkinsonism Agents (Predictors of chronic LH-testosterone axis suppression in male macroprolactinomas with normoprolactinemia on cabergoline)
67. New Pituitary Adenoma Data Have Been Reported by Researchers at First Affiliated Hospital of Wenzhou Medical University (The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists)
68. New Pituitary Adenoma Research from Centre Hospitalier Universitaire de Liege Outlined (Clinical and genetic studies of a three-member familial isolated pituitary adenoma with homogeneous prolactinomas)
69. Research Conducted at Emory University Has Provided New Information about Pituitary Adenoma (The Role of Dopamine Agonists In Pituitary Adenomas)
70. Recent Studies from Royal Veterinary College Add New Data to Proinsulin (Pilot Study Assessing the Use of Cabergoline for the Treatment of Cats With Hypersomatotropism and Diabetes Mellitus)
71. Data on Ovarian Hyperstimulation Syndrome Reported by Researchers at Iuliu Hatieganu University of Medicine and Pharmacy (The Role of High Follicular Levels of Angiotensin Ii and Vascular Endothelial Growth Factor In Anticipating the ...)
72. Study Results from Ludmila Shishkina et al Provide New Insights into Prolactinoma (Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline)
73. New Pituitary Adenoma Study Findings Reported from National and Kapodistrian University of Athens School of Medicine [The natural history and treatment of non-functioning pituitary adenomas (non-functioning PitNETs)]
74. New Pituitary Adenoma Data Have Been Reported by Researchers at Shanghai Jiao Tong University (The Kbtbd6/7-drd2 Axis Regulates Pituitary Adenoma Sensitivity To Dopamine Agonist Treatment)
75. Research Conducted at University of Leipzig Has Updated Our Knowledge about Acromegaly (Medical Therapy of Acromegaly in Germany 2019 - Data from the German Acromegaly Registry)
76. Investigators from Cumhuriyet University Report New Data on Central Nervous System Agents (Role of Dopaminergic System In Oxytocin Analgesia: the Missing Part In a Puzzle)
77. Reports Outline Hyperprolactinemia Study Results from University Hospital Parc Tauli (Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis)
78. Study Findings from University of Oxford Provide New Insights into Neuroscience (Dopamine modulates dynamic decision-making during foraging)
79. New Dopaminergic Antiparkinsonism Agents Study Findings Recently Were Reported by Researchers at University of Basel (OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists)
80. Latvian Biomedical Research and Study Centre (BMC) Researchers Highlight Recent Research in Neuroendocrine Cancer (Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues)
81. Study Data from Stony Brook University Hospital Provide New Insights into Hyperplasia (A Case of Exaggerated Pituitary Hyperplasia in a Pregnant Woman)
82. Study Findings on Acromegaly Reported by a Researcher at Dicle University (Severe osteoarthritis at unexpected age)
83. Studies from V. N. Karazin Kharkiv National University Describe New Findings in Prolactinoma (Experience with Dopamine Agonists in the Treatment of Prolactinomas)
84. Shaheed Beheshti University of Medical Sciences Researchers Update Current Study Findings on Lactation Disorders (Idiopathic granulomatous hypophysitis presenting with galactorrhea, headache, and nausea in a woman: a case report and review of ...)
85. Findings on Endocrinology Reported by Researchers at Kocaeli University (Metastatic MEN1 Syndrome Treated with Lutetium-177 - A Case Report)
86. Findings from University of Oxford Provide New Insights into Dopamine Receptors (Dopamine D2 receptor stimulation modulates the balance between ignoring and updating according to baseline working memory ability)
87. New Dopaminergic Antiparkinsonism Agents Study Results Reported from Payame Noor University (Disposable Electrochemical Sensor Based On Modified Screen Printed Electrode for Sensitive Cabergoline Quantification)
88. Data from H. Lasolle et al Provide New Insights into Acromegaly (Pasireotide-LAR in acromegaly patients treated with a combination therapy: a real-life study)
89. Findings from Agriculture and Agri-Food Canada Update Knowledge of Pituitary Gonadotropins (Review: Inhibition of prolactin as a management tool in dairy husbandry)
90. Research Results from Department of Pharmacy Update Understanding of HIV/AIDS (Cabergoline: a review of its use in the inhibition of lactation for women living with HIV)
91. Data on Prolactinoma Detailed by Researchers at Nanjing University (Bromocriptine and Cabergoline Induce Cell Death In Prolactinoma Cells Via the Erk/egr1 and Akt/mtor Pathway Respectively)
92. Study Data from Hospital Clinic Update Knowledge of Pituitary Adenoma (Cabergoline In the Management of Residual Nonfunctioning Pituitary Adenoma a Single-center, Open-label, 2-year Randomized Clinical Trial)
93. New Findings from University of Tokyo Hospital Yields New Data on Adenomas (A case of functioning gonadotroph adenoma in a reproductive aged woman)
94. Researcher from King Saud bin Abdulaziz University for Health Sciences Details Findings in Hyperprolactinemia (Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center)
95. Findings from University Medical Center Groningen Update Knowledge of Pituitary Cancer (An Aggressive Lactotroph Pituitary Tumor In a Young Male: a Pituitary Carcinoma Without Metastasis)
96. University of Naples Federico II Researchers Add New Study Findings to Research in Metabolic Syndrome (Metabolic effects of prolactin)
97. New Neuroendocrine Cancer Study Results Reported from Shanghai Jiao Tong University School of Medicine (Hydroxychloroquine overcomes cabergoline resistance in a patient with Lactotroph Pituitary neuroendocrine tumor: a case report)
98. Studies in the Area of Temozolomide Therapy Reported from Universidad Nacional del Noroeste de la Provincia de Buenos Aires (Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by ...)
99. Sapienza University of Rome Researcher Reports on Findings in Prolactinoma (Giant Prolactinoma Embedded by Pseudoaneurysm of the Cavernous Carotid Artery Treated with a Tailored Therapeutic Scheme)
100. New Microadenoma Research from Tripler Army Medical Center Discussed (Ectopic Cavernous Sinus Microprolactinoma Treated Medically)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.